Filippo Acconcia

Filippo Acconcia

Sep 18, 2017

Group 6 Copy 26
0
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Rapid Detection of Tuberculosis -SCSU-New Haven iGEM

The World Health Organization reports 9.6 million new Tuberculosis cases in 2014. As a global health issue...

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

Campaign Ended